September 22, 2016
BIOPHYTIS launches the second phase of Sarconeos pharmacokinetics study (SARA-PK) after successful completion of the initial phase. Read the Press Release
BIOPHYTIS launches the second phase of Sarconeos pharmacokinetics study (SARA-PK) after successful completion of the initial phase. Read the Press Release
BIOPHYTIS ready to launch SARA-OBS trial. Read the Press Release
Biophytis will be present at BIOPHARM AMERICA 2016 in Boston, from September 13 to 15
BIOPHYTIS will present at the Rodman & Renshaw 18th Annual Global Investment Conference In New York City, September 11-13, 2016. Read the Press Release
Enrollment of the first subjects in the pharmacokinetics study on Sarcopenia. Read the Press Release
BIOPHYTIS receives approval of bpifrance for an innovation loan of €1.1M to finance the SARA-PK trial. Read the press release
BIOPHYTIS receives Belgian regulatory authorization to start Sarconeos pharmacokinetics study in elderly healthy volunteers (SARA-PK). Read the Press Release
Results of the Combined General Shareholders’ Meeting held on June 10, 2016. Read the Press Release
In french: Assemblée Générale convoquée le 10 juin 2016. Téléchargez le communiqué de presse
BIOPHYTIS unveils its clinical development strategy in the United States, as it communicates its 2015 Document de Référence. Download the Press Release